Low levels of USP18 mRNA were detected in the peripheral blood mononuclear cells of patients with relapsing-remitting MS (RRMS), which could possibly lead to enhanced TNF and type-I interferon (IFN) signaling as these DUBs are major negative regulators of immune signaling [80]. Here, IFNA1 is linked to relapsing-remitting multiple sclerosis.